CJC-1295 (No DAC)· 10 mg
- Sealed lyophilized vial, lot code on the label
- Same-day weekday shipping before 2PM ET
Ships as lyophilized powder for laboratory research use.
Need 10+ vials? Email sales@truebondlabs.com for wholesale pricing.
CJC-1295 (No DAC) in the literature
CJC-1295 without DAC, also cataloged as Modified GRF (1-29), is a 29-amino-acid analogue of growth-hormone-releasing hormone carrying four amino-acid substitutions that increase its resistance to enzymatic breakdown. The "No DAC" designation means this version omits the drug affinity complex found on the DAC variant, a structural difference many laboratories specifically require. TrueBond Labs packages it as 10 mg of lyophilized powder in a 3 mL vial, verified to at least 99% purity by independent HPLC testing with MS identity confirmation.
In preclinical settings, CJC-1295 (No DAC) has been studied in research examining growth-hormone-axis signaling and GHRH receptor interactions in laboratory models. Such work maps how modified GRF analogues behave chemically and pharmacologically in vitro; it establishes no application outside the laboratory, and this research compound is sold on a research-use-only basis with no instructions provided. Any mention of the surrounding literature here is descriptive context about a research area, never a suggestion of outcomes.
Before you buy CJC-1295, you can inspect the current lot's certificate of analysis at /lab-reports, complete with HPLC purity and mass-spec identity data, since every certificate is public rather than available on request. Store the lyophilized vial at −20°C for 24+ months of stability.
All information is provided for educational context on laboratory research only and is not a claim of therapeutic effect. This product is not for human or animal use.
Product & terms of sale
Contents
CJC-1295 (No DAC) (10 mg), supplied as lyophilized powder for laboratory research applications.
Intended use
This product is sold strictly for in-vitro laboratory research by qualified professionals. It is not for human or animal consumption, and no usage instructions are provided or implied.
Legal disclaimer
Not evaluated or approved by the FDA. Nothing on this page constitutes a claim of therapeutic, diagnostic, or preventive benefit. See our full research disclaimer.
Terms of sale
By purchasing, you affirm you are a qualified researcher (21+) and accept our Terms & Conditions and research-use-only requirements.
CJC-1295 (No DAC): frequently asked questions
What is CJC-1295 No DAC?
CJC-1295 No DAC, also called Modified GRF (1-29), is a synthetic 29-amino-acid analogue of growth-hormone-releasing hormone featuring four substitutions that slow enzymatic degradation. Unlike the DAC version, it lacks the drug affinity complex moiety. TrueBond Labs supplies it in a 10 mg lyophilized vial intended solely for in-vitro laboratory research.
What is the difference between CJC-1295 with DAC and without DAC?
The DAC variant carries an attached drug affinity complex that binds serum albumin, substantially extending its persistence in experimental systems; the No DAC version sold here omits that group, retaining only the four stabilizing amino-acid substitutions of Mod GRF (1-29). Laboratories select between the two based on the chemical profile their protocols call for.
Is TrueBond Labs CJC-1295 third-party tested?
It is. An independent third-party laboratory runs HPLC purity analysis and mass-spectrometry identity checks on every CJC-1295 lot, and TrueBond Labs releases only batches at 99% purity or better. The certificate of analysis for each lot is published on our Lab Reports page under its lot code as results are released, filed under the lot code shown on the vial label.
How long does CJC-1295 stay stable in storage?
Kept lyophilized at −20°C, CJC-1295 remains stable for upwards of 24 months. To protect the compound, avoid cycling the vial between frozen and thawed states and store it away from strong light.